Quality of life (either short or long term) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · adults with neuropathic pain
1 finding from 1 review
At least 50% reduction in pain · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing any serious adverse events · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life FACT/the GOG‐Ntx questionnaire scores (0 ‐ 100, lower score = better) · adults with neuropathic pain
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis
1 finding from 1 review
Function (short‐term) DRI scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis
1 finding from 1 review
Quality of life (short‐term) GSI scale from 0 to 10 (higher is worse quality of life). · patients with hip osteoarthritis
1 finding from 1 review
Number of participants reporting an adverse event · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Nausea · women undergoing regional anaesthesia for caesarean section
It is very uncertain whether acupressure/acupuncture changes nausea ‐ intraoperative compared with placebo (very low certainty).
2 findings from 1 review
Vomiting ‐ intraoperative · women undergoing regional anaesthesia for caesarean section
Acupressure/acupuncture may leads to lower vomiting ‐ intraoperative compared with placebo (low certainty).
1 finding from 1 review
Vomiting ‐ postoperative · women undergoing regional anaesthesia for caesarean section
It is very uncertain whether acupressure/acupuncture changes vomiting ‐ postoperative compared with placebo (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global state: Not improved, endpoint ‐ medium‐term (various similar criteria) · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS changes global state: Not improved, endpoint ‐ medium‐term (various similar… compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Mental state: PANSS (not improved, reduced rated < 25%, short‐term) · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS changes mental state: PANSS (not improved, reduced rated < 25%, short‐term) compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS changes behaviour: Leaving the study early (short‐term) compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Health service outcomes: 2. Hospital bed‐days by 12 months · patients with schizophrenia
1 finding from 1 review